CareLit · DOI-Nachweis · Klinische Pädiatrie
Histone deacetylases 5 and 9 are novel markers for medulloblastoma risk stratification and potential drug targets for therapy
DOI 10.1055/s-0029-1222661
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Milde, I Oehme, S Pfister, A Korshunov, A Kopp-Schneider, M Remke, H Deubzer, M Lodrini, A von Deimling, O Witt
ZeitschriftKlinische Pädiatrie
Ausgabe05/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Medulloblastomas are the most common malignant brain tumors in childhood and 5-year survival rates of large-cell/anaplastic medulloblastoma or metastasized disease are as low as 30–40%. Furthermore, surviving children suffer from high morbidity due to therapy-related side effects. Thus, therapies targeting tumors in a specific manner, as opposed to the current surgery/irradiation/chemotherapy protocols, are urgently…
Zitieren
Zitierempfehlung
T Milde, I Oehme, S Pfister, A Korshunov, A Kopp-Schneider, M Remke, H Deubzer, M Lodrini, A von Deimling, O Witt (2009) Histone deacetylases 5 and 9 are novel markers for medulloblastoma risk stratification and potential drug targets for therapy. Klinische Pädiatrie (05). https://doi.org/10.1055/s-0029-1222661
Mit CareLit weiterarbeiten